Kundhal K, Lok C E
University Health Network-Toronto General Hospital, University of Toronto, Toronto, Canada.
Nephron Clin Pract. 2005;101(2):c47-52. doi: 10.1159/000086221. Epub 2005 Jun 7.
Cardiovascular disease (CVD) is the most common cause of death in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The clinical epidemiology of CVD in CKD is challenging due to a prior lack of standardized definitions of CKD, inconsistent measures of renal function, and possible alternative effects of 'traditional' CVD risk factors in patients with CKD. These challenges add to the complexity of the role of renal impairment as the cause or the consequence of cardiovascular disease. The goal of this review is to summarize the current evidence on: (1) the incidence and prevalence of CVD in chronic renal insufficiency and in ESRD, (2) risk factors for CVD in CKD, (3) the outcomes of patients with renal failure with CVD, and (4) CKD as a risk factor for CVD. The epidemiological associations implicating the huge burden of CVD throughout all stages of CKD highlight the need to better understand and implement adequate screening, and diagnostic and treatment strategies.
心血管疾病(CVD)是慢性肾脏病(CKD)和终末期肾病(ESRD)患者最常见的死亡原因。由于既往缺乏CKD的标准化定义、肾功能测量方法不一致以及CKD患者中“传统”CVD危险因素可能存在的替代效应,CKD中CVD的临床流行病学具有挑战性。这些挑战增加了肾功能损害作为心血管疾病病因或后果的作用的复杂性。本综述的目的是总结关于以下方面的现有证据:(1)慢性肾功能不全和ESRD中CVD的发病率和患病率,(2)CKD中CVD的危险因素,(3)患有CVD的肾衰竭患者的结局,以及(4)CKD作为CVD的危险因素。涉及CKD各阶段CVD巨大负担的流行病学关联凸显了更好地理解和实施充分筛查、诊断及治疗策略的必要性。